SCHEMBL4757218

SCHEMBL4757218

CCCc1cnc(NC(=O)c2ccc(C)c(Cl)c2)s1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 1/20 0.48
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
LMNA P02545 1/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
POLB P06746 1/20 0.47
KDM4E B2RXH2 1/20 0.46
SCD O00767 2/20 0.46
PAX8 Q06710 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
MAPT P10636 3/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
FDPS P14324 1/20 0.45
CDK2 P24941 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756969 0.80 FDPS (0.46) NPC1RAB9ALMNAALDH1A1TSHR
SCHEMBL4757358 0.77 MAPT (0.50) NPC1RAB9ALMNAALDH1A1TSHR
SCHEMBL16607214 0.76 LMNA (0.59) NPC1RAB9ALMNAALDH1A1MEN1
SCHEMBL10253529 0.73 RAB9A (0.67) STAT3NPC1RAB9ALMNAALDH1A1
SCHEMBL18135139 0.72 CDK2 (0.64) LMNAALDH1A1MEN1KMT2AMAPT
SCHEMBL4938271 0.72 SCD (0.48) STAT3NPC1RAB9ALMNAMEN1
SCHEMBL15426983 0.71 SMN1; SMN2 (0.66) STAT3NPC1RAB9ALMNAALDH1A1
SCHEMBL8594861 0.71 ALDH1A1 (0.57) NPC1RAB9ALMNAALDH1A1TSHR
SCHEMBL13265891 0.71 KDM4E (0.58) NPC1RAB9AALDH1A1MEN1KMT2A
SCHEMBL4756940 0.70 GPR27 (0.40) NPC1RAB9ALMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885NPC1 585/4885RAB9A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.